Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:28 pm Purchase |
2022-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
Redmile Group LLC | 3,878,599 8.000% |
795,098 (+25.79%) |
Filing History |
| 2023-02-14 4:08 pm Sale |
2022-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
Third Rock Ventures III L.P. | 2,132,867 4.400% |
-3,706,293 (-63.47%) |
Filing History |
| 2023-02-13 12:37 pm Purchase |
2022-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
CHI Advisors LLC | 3,199,892 6.560% |
630,413 (+24.53%) |
Filing History |
| 2023-02-09 12:31 pm Sale |
2023-02-09 | 13G | Pliant Therapeutics, Inc. PLRX |
FMR CORP | 4,393,231 9.010% |
-1,752,187 (-28.51%) |
Filing History |
| 2022-08-31 4:05 pm Unchanged |
2022-08-08 | 13G | Pliant Therapeutics, Inc. PLRX |
Novartis Institutes for BioMedical Research Inc. | 2,153,526 4.400% |
0 (Unchanged) |
Filing History |
| 2022-08-10 08:10 am Purchase |
2022-08-09 | 13G | Pliant Therapeutics, Inc. PLRX |
FMR CORP | 6,145,418 12.644% |
2,672,847 (+76.97%) |
Filing History |
| 2022-06-10 11:04 am Sale |
2022-06-09 | 13G | Pliant Therapeutics, Inc. PLRX |
FMR CORP | 3,472,571 9.600% |
-1,933,278 (-35.76%) |
Filing History |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
Redmile Group LLC | 3,083,501 8.600% |
-304,875 (-9.00%) |
Filing History |
| 2022-02-14 11:55 am Sale |
2021-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
Eventide Asset Management, LLC | 42,499 0.100% |
-2,795,626 (-98.50%) |
Filing History |
| 2022-02-11 1:51 pm Purchase |
2021-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
CHI Advisors LLC | 2,569,479 7.130% |
214,680 (+9.12%) |
Filing History |
| 2022-02-09 10:24 am Purchase |
2022-02-08 | 13G | Pliant Therapeutics, Inc. PLRX |
FMR CORP | 5,405,849 14.999% |
83,693 (+1.57%) |
Filing History |
| 2021-03-02 3:41 pm Purchase |
2020-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
CHI Advisors LLC | 2,354,799 6.600% |
2,354,799 (New Position) |
Filing History |
| 2021-02-16 4:17 pm Purchase |
2020-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
Third Rock Ventures III L.P. | 5,839,160 16.500% |
5,839,160 (New Position) |
Filing History |
| 2021-02-16 4:08 pm Sale |
2020-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
Redmile Group LLC | 3,388,376 9.600% |
-22,281 (-0.65%) |
Filing History |
| 2021-02-12 4:11 pm Purchase |
2020-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
Eventide Asset Management, LLC | 2,838,125 8.000% |
2,838,125 (New Position) |
Filing History |
| 2021-02-08 10:29 am Sale |
2021-02-05 | 13G | Pliant Therapeutics, Inc. PLRX |
FMR CORP | 5,322,156 15.000% |
-10,545 (-0.20%) |
Filing History |
| 2020-07-10 11:38 am Purchase |
2020-07-09 | 13G | Pliant Therapeutics, Inc. PLRX |
FMR CORP | 5,332,701 14.999% |
5,332,701 (New Position) |
Filing History |
| 2020-06-15 4:40 pm Purchase |
2020-06-05 | 13G | Pliant Therapeutics, Inc. PLRX |
Novartis Institutes for BioMedical Research Inc. | 2,153,526 6.100% |
2,153,526 (New Position) |
Filing History |
| 2020-06-09 4:18 pm Purchase |
2020-06-05 | 13G | Pliant Therapeutics, Inc. PLRX |
Redmile Group LLC | 3,410,657 9.600% |
3,410,657 (New Position) |
Filing History |